Business Wire

NTT to Extend the World’s Largest Connected Stadium to The Tour de France Femmes avec Zwift

Share

NTT Ltd., a leading IT infrastructure and services company, is using technology and innovation to equally enhance the fan experience across both the Tour de France and the Tour de France Femmes avec Zwift.

The 2022 event will see the inaugural women’s race which will start on the Champs-Élysées on July 24th 2022, prior to the conclusion of the men’s race on the same day. The women’s race will feature 24 teams of six riders and will conclude on July 31st 2022 in La Super Planche des Belles Filles. NTT has been the official technology partner of the Tour de France for the past eight years.

For the first time ever, and at a time when interest in women’s cycling is on the rise, NTT will bring fans closer to the action and shine a light on this notable occasion through the implementation of real-time tracking of the riders, the Race Center and its predictive modelling strategy to support the race. The model also includes @letourdata, the data-driven content channel that helps tell the race’s stories over social media and broadcast. Rider and team profiles will uncover unique insights into the women’s pro peloton.

In addition to this, NTT alongside A.S.O. will deliver a host of new and enhanced digital experiences to engage fans around the world, both at home and along the roadside. These experiences include:

  • The Digital Human: NTT has developed an interactive kiosk featuring an AI-generated realistic human avatar, trained on the relevant race and tourist information. This technology will be deployed at the official fan store at the Grand Depart in Copenhagen and in NTT’s Technical Truck at the end of every stage.
  • An enhanced digital twin: Last year, NTT created a digital twin of the event, which enabled staff to gain real-time visibility and ultimately streamline operations to ensure the continuity and resilience of the race. This year, the technology has enhanced connectivity to provide smarter event operations, enabling quicker, more informed decisions in a highly complex and ever-changing environment.
  • Strava partnership: NTT’s live storytelling channel, @letourdata, in collaboration with Strava, will be bringing real-time comparisons between amateurs, pros, and King of the Mountain (or fastest known times) to social media and broadcast during the race.

“With female cycling on the rise as we saw through the 2020 edition of La Course by Le Tour de France avec FDJ with over 30 million TV audience viewers, we’re incredibly proud to continue to help widen the fan base and be part of this historic milestone for female cycling. There is still much more work to be done to achieve equality in cycling, but we’re extremely passionate about doing what we can to increase the accessibility of the sport. Our technology means we can bring the action to more fans than ever before,” says Michele McGuire, Vice President of Managed Services Delivery, Europe at NTT Ltd.

“When it comes to the technology, both races are highly dynamic and require access to real-time information to ensure continuous and smooth operations while creating more informed and engaged fans. NTT’s full stack of solutions and expertise will continue to support the A.S.O. in transforming the famous race,” McGuire adds.

“At A.S.O., we’re extremely proud to be launching Tour de France Femmes avec Zwift and to be able to count on key technical partners such as NTT. Our partnership with NTT is well known for bringing the fans closer to the action. 2022 marks a momentous occasion for women’s cycling, and fans around the world are extremely excited to witness the first edition of the Tour de France Femmes avec Zwift,” said Julien Goupil, Media & Partnerships Director at A.S.O..

NTT’s role as the official technology partner to Tour de France Femmes avec Zwift, means NTT will now support A.S.O. at four of its female events, including Paris-Roubaix Femmes avec Zwift, Flèche Wallonne Femmes, and Liège-Bastogne-Liège Femmes. To find out more about how NTT supports A.S.O., visit: https://services.global.ntt/tourdefrance

Follow @letourdata on Twitter and look for NTT’s race predictions using #NTTPredictor.

ENDS

About Amaury Sport Organisation

Amaury Sport Organisation is a company that owns, designs and organises top international sporting events. Specialised in the ‘non-stadia’ events, it has in-house knowledge of professions linked to organisation, media and sales of sports events. A.S.O. organises 250 days of competition per year, with 90 events in 30 countries. A.S.O. is involved in 5 major sports including cycling with the Tour de France, motor sports with the Dakar, mass events with the Schneider Electric Marathon de Paris, golf with the Lacoste Ladies Open de France and sailing with production and distribution of images for prestigious races. Amaury Sport Organisation is a subsidiary of the Amaury Group, media and sport group that owns the newspaper L’Équipe.

About NTT Ltd.

NTT Ltd. is a leading IT infrastructure and services company. With revenues of over USD 10 billion, we operate in more than 200 countries and regions, and serve 5,000 clients across multiple industries. Through technology and innovation, we deliver a secure and connected future that empowers our people, clients and communities. We lay the foundation for organizations’ edge-to-cloud networking ecosystem, simplify the complexity of their workloads across multicloud environments, and innovate at the edge of their IT environments, where networks, cloud and applications converge. On the journey towards a software-defined future, we support organizations with platform-delivered infrastructure services. As part of the global NTT Corporation, we serve 65% of the Fortune Global 500 and 80% of the Fortune Global 100. We enable a connected future.

Visit us at services.global.ntt

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Inquiries:
Tour de France - www.letour.fr
Fabrice Tiano
ftiano@aso.fr - +33(0)6.33.86.28.64

Tour de France Femmes avec Zwift - www.letourfemmes.fr
Thida Vuillaume
tvuillaume@aso.fr - +33(0)6.40.29.69.26

Hotwire for NTT Ltd.
Hannah Lock
NTT@hotwireglobal.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Unveils Nourish Innovation Lab in Union Beach, New Jersey19.8.2022 12:55:00 CEST | Press release

IFF (NYSE:IFF) today announced the opening of its new Nourish Innovation Lab at the company’s Union Beach, New Jersey research and development center. In the state-of-the-art lab, scientists—including flavorists and food designers—will leverage tools, technologies and ingredient expertise to offer customers full product design, driving growth in the global food and beverage markets by fast forwarding innovation. “This new facility is a testament to how we pioneer innovation and drive speed to market and accessibility to our customers,” said Nicolas Mirzayantz, president of Nourish, IFF. “We will nurture an innovation project from concept to kitchen table, under one roof. Using our scientific knowhow, application excellence and full portfolio of ingredients, we’ll improve the taste and nutrition profiles of next-generation food and beverages. With our new culinary kitchen, we’re enabling technology focused on the consumer-eating experience, taking food development out of the traditional

PUMA Ambassador and European Champion Gianmarco Tamberi Talks “Only See Great”19.8.2022 11:52:00 CEST | Press release

Six years after his first gold medal, Tamberi takes back the European title and speaks about his motivation to keep performing at the highest level in a video interview with sports company PUMA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220819005125/en/ Six years after his first gold medal, Tamberi takes back the European title and speaks about his motivation to keep performing at the highest level in a video interview with sports company PUMA. (Photo: Business Wire) With the ‘Only See Great’ campaign, PUMA explores the career path of its brand ambassadors, as they talk about their own pursuit of greatness, listening to their hearts, and finding a vision that no one else can see. In the interview, Gianmarco talks about his very first successes and extraordinary performance at the Olympic Games in Tokyo. “That feeling that I had that day, that happiness I couldn’t even imagine that could exist. It’s something that was co

Kyowa Kirin Receives European Commission Approval for Use of CRYSVITA ® ▼ (burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)19.8.2022 10:30:00 CEST | Press release

Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the European Commission (EC) approved CRYSVITA® (burosumab) for the treatment of FGF23-related hypophosphataemia in Tumour-Induced Osteomalacia (TIO) associated with phosphaturic mesenchymal tumours (PMTs) that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.1 CRYSVITA is also already licensed in the EU for use in the rare disease X-Linked Hypophosphataemia (XLH), for children and adolescents between 1 and 17 years of age with radiographic evidence of bone disease, and in adults.2 Also known as oncogenic osteomalacia, TIO is an acquired disorder caused by typically small, slow-growing, benign PMTs.3,4 It is a rare condition with fewer than 1000 cases reported in the medical literature,4 which mainly affects adults and with a mean onset age of 40 – 45 years.3,5 TIO is associated with progressive and debilitating musculoskeletal deficits,6,7 ultimately having a detr

Kapruvia ® approved in Switzerland with additional regulatory decisions expected in H2 202219.8.2022 07:00:00 CEST | Press release

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that they have received approval for Kapruvia® from the Swiss Agency for Therapeutic Products (Swissmedic). Kapruvia® will be the first therapy available for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult hemodialysis patients. Swissmedic approval for Kapruvia® follows approvals by the U.S. Food and Drug Administration, by the European Medicines Agency, by the UK Medicines and Healthcare products Regulatory Agency, as well as by Health Canada. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220818005552/en/ “The approval of Kapruvia® in Switzerland is the next step on our journey to bring this breakthrough treatment to hemodialysis patients living with CKD-associated pruritus around the world,” said Dr. Klaus Henning Jensen, Chief Medical Officer of CSL Vifor. “There is a

European Commission Approves Celltrion Healthcare’s Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer19.8.2022 04:47:00 CEST | Press release

Celltrion Healthcare announced today that the European Commission (EC) has approved Vegzelma™ (CT-P16), a biosimilar bevacizumab referencing EU-approved Avastin®, for the treatment of metastatic breast cancer, non-small cell lung cancer, advanced and/or metastatic renal cell cancer, metastatic carcinoma of the colon or rectum, ovarian cancer and cervical cancer. “The European Commission’s approval of Vegzelma™ will increase access to treatment for patients living with certain types of cancer at an affordable price,” said Kevin Byoung Seo Choi, Senior Vice President and Head of Marketing Division at Celltrion Healthcare. “With proven similarities in efficacy and safety compared to the reference product Avastin®, Vegzelma™ will be available to treat some of the most commonly diagnosed cancers, which collectively affect hundreds of thousands of European patients each year.” The EC approval of Vegzelma™ follows the recommendation for marketing authorisation issued by the Committee for Medi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom